Speaker illustration

Doctor Joan Elias Walter

University Hospital Basel, Basel (Switzerland)

Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study

Event: ESC Congress 2019

Topic: Diagnostic Methods

Session: Risk factors for Coronary Artery Disease

Thumbnail

Extending the use of high-sensitivity cardiac troponin to patients with suspected stable coronary artery disease: insights from two large diagnostic studies

Event: ESC Congress 2018

Topic: Diagnostic Methods

Session: Biomarkers in acute coronary syndromes

Thumbnail

Use of high-sensitivity cardiac troponin in patients with known coronary artery disease: insights from two large diagnostic studies

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease epidemiology and outcomes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb